Sung H, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  PubMed  CAS  Google Scholar 

Siegel RL, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. https://doi.org/10.3322/caac.21763.

Article  PubMed  Google Scholar 

Early Breast Cancer Trialists’, Collaborative G, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–16. https://doi.org/10.1016/S0140-6736(11)61629-2.

Article  Google Scholar 

Flores RM, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg. 2008;135(3):620–6. https://doi.org/10.1016/j.jtcvs.2007.10.054.

Article  PubMed  Google Scholar 

Gronchi A, et al. Variability in patterns of recurrence after resection of primary Retroperitoneal Sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS Working Group. Ann Surg. 2016;263(5):1002–9. https://doi.org/10.1097/SLA.0000000000001447.

Article  PubMed  Google Scholar 

Mahvi DA, et al. Local Cancer recurrence: the realities, challenges, and opportunities for New therapies. CA Cancer J Clin. 2018;68(6):488–505. https://doi.org/10.3322/caac.21498.

Article  PubMed  PubMed Central  Google Scholar 

Pfister D, et al. Early salvage radiotherapy following radical prostatectomy. Eur Urol. 2014;65(6):1034–43. https://doi.org/10.1016/j.eururo.2013.08.013.

Article  PubMed  Google Scholar 

Subotic D, Van Schil P, Grigoriu B. Optimising treatment for post-operative lung cancer recurrence. Eur Respir J. 2016;47(2):374–8. https://doi.org/10.1183/13993003.01490-2015.

Article  PubMed  CAS  Google Scholar 

Cescon DW, et al. Therapeutic targeting of minimal residual disease to prevent late recurrence in hormone-receptor positive breast Cancer: challenges and New approaches. Front Oncol. 2021;11:667397. https://doi.org/10.3389/fonc.2021.667397.

Article  PubMed  CAS  Google Scholar 

Jacome AA, Johnson B. Minimal Residual Disease in Colorectal Cancer: Are We Finding the Needle in a Haystack? Cells, 2023. 12(7)10.3390/cells12071068.

de Perrot M, et al. Trimodality therapy with induction chemotherapy followed by Extrapleural Pneumonectomy and Adjuvant High-Dose Hemithoracic Radiation for Malignant Pleural Mesothelioma. J Clin Oncol. 2009;27(9):1413–8. https://doi.org/10.1200/jco.2008.17.5604.

Article  PubMed  Google Scholar 

Sakuramoto S, et al. Adjuvant chemotherapy for gastric Cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810–20. https://doi.org/10.1056/NEJMoa072252.

Article  PubMed  CAS  Google Scholar 

Group NM-aC, et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet. 2010;375(9722):1267–77. https://doi.org/10.1016/s0140-6736(10)60059-1.

Article  Google Scholar 

Neoptolemos JP, et al. Adjuvant chemotherapy with Fluorouracil Plus Folinic Acid vs Gemcitabine following pancreatic Cancer resection: a Randomized Controlled Trial. JAMA. 2010;304(10):1073–81. https://doi.org/10.1001/jama.2010.1275.

Article  PubMed  CAS  Google Scholar 

Graboyes EM, Divi V, Moore BA. Head and Neck Oncology Is on the National Quality Sidelines No Longer—Put Me in, Coach. JAMA Otolaryngology–Head & Neck Surgery, 2022. 148(8)10.1001/jamaoto.2022.1389.

Aloia TA, et al. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol. 2014;110(2):107–14. https://doi.org/10.1002/jso.23626.

Article  PubMed  PubMed Central  Google Scholar 

Kiong KL et al. Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival. Oral Oncology, 2022. 13010.1016/j.oraloncology.2022.105906.

Divi V, et al. Reducing the time from surgery to Adjuvant Radiation Therapy: an Institutional Quality Improvement Project. Otolaryngology–Head Neck Surg. 2018;159(1):158–65. https://doi.org/10.1177/0194599818768254.

Article  Google Scholar 

Hiller JG, et al. Perioperative events influence cancer recurrence risk after surgery. Nat Rev Clin Oncol. 2018;15(4):205–18. https://doi.org/10.1038/nrclinonc.2017.194.

Article  PubMed  Google Scholar 

Hanin L, Rose J. Suppression of metastasis by primary tumor and acceleration of Metastasis following primary tumor resection: a Natural Law? Bull Math Biol. 2018;80(3):519–39. https://doi.org/10.1007/s11538-017-0388-9.

Article  PubMed  Google Scholar 

Kim EY, Hong TH. Changes in total lymphocyte count and neutrophil-to-lymphocyte ratio after curative pancreatectomy in patients with pancreas adenocarcinoma and their prognostic role. J Surg Oncol. 2019;120(7):1102–11. https://doi.org/10.1002/jso.25725.

Article  PubMed  CAS  Google Scholar 

Tang F, et al. Surgical trauma-induced immunosuppression in cancer: recent advances and the potential therapies. Clin Transl Med. 2020;10(1):199–223. https://doi.org/10.1002/ctm2.24.

Article  PubMed  PubMed Central  Google Scholar 

Togashi Y, Shitara K, Nishikawa H. Regulatory T cells in cancer immunosuppression - implications for anticancer therapy. Nat Rev Clin Oncol. 2019;16(6):356–71. https://doi.org/10.1038/s41571-019-0175-7.

Article  PubMed  CAS  Google Scholar 

Cata JP, et al. Inflammation and pro-resolution inflammation after hepatobiliary surgery. World J Surg Oncol. 2017;15(1):152. https://doi.org/10.1186/s12957-017-1220-6.

Article  PubMed  PubMed Central  Google Scholar 

Ramirez MF, et al. Innate immune function after breast, lung, and colorectal cancer surgery. J Surg Res. 2015;194(1):185–93. https://doi.org/10.1016/j.jss.2014.10.030.

Article  PubMed  CAS  Google Scholar 

Velasquez JF, et al. Impaired Immune function in patients undergoing surgery for Bone Cancer. Anticancer Res. 2015;35(10):5461–6.

PubMed  CAS  Google Scholar 

Zhang H, et al. Intraoperative lidocaine infusion in patients undergoing pancreatectomy for pancreatic cancer: a mechanistic, multicentre randomised clinical trial. Br J Anaesth. 2022;129(2):244–53. https://doi.org/10.1016/j.bja.2022.03.031.

Article  PubMed  CAS  Google Scholar 

Angka L, et al. Natural killer cell IFNgamma secretion is profoundly suppressed following colorectal Cancer surgery. Ann Surg Oncol. 2018;25(12):3747–54. https://doi.org/10.1245/s10434-018-6691-3.

Article  PubMed  Google Scholar 

Karnezis T, et al. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell. 2012;21(2):181–95. https://doi.org/10.1016/j.ccr.2011.12.026.

Article  PubMed  CAS  Google Scholar 

Hu Z, et al. Neutrophil extracellular traps induce IL-1beta production by macrophages in combination with lipopolysaccharide. Int J Mol Med. 2017;39(3):549–58. https://doi.org/10.3892/ijmm.2017.2870.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Vicente D, et al. Impact of epidural analgesia on the systemic biomarker response after hepatic resection. Oncotarget. 2019;10(5):584–94. https://doi.org/10.18632/oncotarget.26549.

Article  PubMed  PubMed Central  Google Scholar 

Sun Z, et al. Determining the optimal timing for initiation of adjuvant chemotherapy after resection for stage II and III Colon cancer. Dis Colon Rectum. 2016;59(2):87–93. https://doi.org/10.1097/dcr.0000000000000518.

Article  PubMed  Google Scholar 

G Des Guetz, et al. Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. Eur J cancer (Oxford England: 1990). 2010;46(6):1049–55. https://doi.org/10.1016/j.ejca.2010.01.020.

Seagle B-LL, et al. Chemotherapy delay after primary debulking surgery for ovarian cancer. Gynecol Oncol. 2017;144(2):260–5.